Targeting EphA2 suppresses hepatocellular carcinoma initiation and progression by dual inhibition of JAK1/STAT3 and AKT signaling

Hepatocellular carcinoma (HCC) remains one of the deadliest malignancies worldwide. One major obstacle to treatment is a lack of effective molecular-targeted therapies. In this study, we find that EphA2 expression and signaling are enriched in human HCC and associated with poor prognosis. Loss of Ep...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cell Rep
Main Authors: Wang, Hao, Hou, Wei, Perera, Aldeb, Bettler, Carlee, Beach, Jordan R., Ding, Xianzhong, Li, Jun, Denning, Mitchell F., Dhanarajan, Asha, Cotler, Scott J., Joyce, Cara, Yin, Jun, Ahmed, Fowsiyo, Roberts, Lewis R., Qiu, Wei
Formato: Artigo
Idioma:Inglês
Publicado em: 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7954228/
https://ncbi.nlm.nih.gov/pubmed/33626345
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.celrep.2021.108765
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados